Baby Oral Pain Relief
Natural health product licensed in Canada
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcarea carbonica Source : Coquille d'huître | 12 X | Not calculated |
| Calcarea phosphorica Source : Phosphate de calcium | 12 X | Not calculated |
| Coffea cruda Source : Graine séchée non grillée | 6 X | Not calculated |
| Ferrum phosphoricum Source : Ferrous phosphate BPC73 (Synthetic) | 12 X | Not calculated |
| Arnica montana Source : Plante entière y compris la racine | 30 X | Not calculated |
| Chamomilla Source : Plante entière fleurissante | 12 X | Not calculated |
Non-medicinal ingredients
Gomme arabique (acacia), Lactose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | maximum: 6 months | 1 Comprimé | minimum: 1 Tous les jours ; maximum: 12 Tous les jours |
| Enfants | minimum: 6 months ; maximum: 24 months | 2 Comprimé | minimum: 1 Tous les jours ; maximum: 12 Tous les jours |
| Enfants | minimum: 2 years | 2 Comprimé | minimum: 1 Tous les jours ; maximum: 12 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Homeopathic medicine used for symptoms of teething and oral pain or discomfort, including: gum sensitivity swelling or soreness of gums, irritability.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ask a doctor if: symptoms persist for more than 72 hours or worsen, swelling increases, rash or fever over 38oC (101oF) is present or develops, irritation, pain or redness persists or worsens. Keep out of reach of children. Do not use if tamper-evident seal is broken or missing
Product record
- Licence holder
- Hyland's Consumer Health, Inc. (f/k/a Standard Homeopathic Company)
- NPN or DIN-HM
- 80083068
- Status
- Active licence
- Licence date
- 13 February 2018
- Revision date
- 11 August 2022
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Homéopathique
Source
Official Health Canada record, licence 80083068
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Baby Oral Pain Relief (Hyland's Consumer Health, Inc. (f/k/a Standard Homeopathic Company)): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80083068-baby-oral-pain-relief, updated 11 August 2022.